82172604/National Natural Science Foundation of China[Grants and Funding] - Search Results

Save citations to file

Your saved search

Your RSS Feed

Year	Number of Results
2022	1
2023	1
2024	1
2025	1

Page 1

[¹⁷⁷Lu]Lu-labeled anti-claudin-18.2 antibody demonstrated radioimmunotherapy potential in gastric cancer mouse xenograft models.

Zeng Z, Li L, Tao J, Liu J, Li H, Qian X, Yang Z, Zhu H. Zeng Z, et al. Eur J Nucl Med Mol Imaging. 2024 Apr;51(5):1221-1232. doi: 10.1007/s00259-023-06561-1. Epub 2023 Dec 8. Eur J Nucl Med Mol Imaging. 2024. PMID: 38062170

[Preliminary effects of toripalimab combined with axitinib in the treatment of advanced renal cell carcinoma].

Zhou L, Xu HY, Yan XQ, Li SM, Chi ZH, Si L, Cui ZL, Li J, Wu XW, Guo J, Sheng XN. Zhou L, et al. Zhonghua Yi Xue Za Zhi. 2022 Jan 11;102(2):136-140. doi: 10.3760/cma.j.cn112137-20210527-01225. Zhonghua Yi Xue Za Zhi. 2022. PMID: 35012303 Chinese.

A prognostic model for survival of patients with metastatic upper tract urothelial carcinoma with first-line systemic therapy.

Li S, Wei J, Xu H, Wu X, Li J, Zhou L, Yan X, Tang B, Si L, Cui C, Chi Z, Guo J, Sheng X. Li S, et al. World J Urol. 2025 Apr 2;43(1):206. doi: 10.1007/s00345-025-05592-7. World J Urol. 2025. PMID: 40172675

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

3 results

Results by year

Search Page

Filters

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

3 results

Results by year